ITI Pharma and Healthcare Fund
Current NAV
₹18.44
1Y Return
--
3Y Return
--
5Y Return
--
AUM
--
Expense Ratio (Direct)
--
Category
Sectoral
Top Holdings
Top 20 stocks held by this fund as of May 2026 (Source: AMC monthly disclosure)
SUN PHARMACEUTICALS INDUSTRIES
Pharmaceuticals & Biotechnology
DIVI LABORATORIES LTD
Pharmaceuticals & Biotechnology
APOLLO HOSPITALS ENTERPRISE LT
Healthcare Services
Laurus Labs Limited
Pharmaceuticals & Biotechnology
Torrent Pharmaceuticals Limited
Pharmaceuticals & Biotechnology
Max Healthcare Institute Limited
Healthcare Services
Aurobindo Pharma Limited
Pharmaceuticals & Biotechnology
Dr Reddys Laboratories Limited
Pharmaceuticals & Biotechnology
Lupin Limited
Pharmaceuticals & Biotechnology
Cipla Limited
Pharmaceuticals & Biotechnology
Fortis Health Care Ltd
Healthcare Services
Neuland Laboratories Limited
Pharmaceuticals & Biotechnology
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
Cohance Lifesciences Limited
Pharmaceuticals & Biotechnology
Abbott India Limited
Pharmaceuticals & Biotechnology
Mankind Pharma Limited
Pharmaceuticals & Biotechnology
Aster DM Healthcare Limited
Healthcare Services
Sai Life Sciences Limited
Pharmaceuticals & Biotechnology
Shaily Engineering Plastics Limited
Consumer Durables
IPCA Laboratories Limited
Pharmaceuticals & Biotechnology
📋 All returns shown are for Direct-Growth plan. Data from AMC monthly portfolio disclosure.
SIP in ITI Pharma and Healthcare Fund
If you had invested ₹10,000/month via SIP:
1 Year SIP
₹127,200
Invested: ₹1,20,000
3 Year SIP
₹403,200
Invested: ₹3,60,000
5 Year SIP
₹744,000
Invested: ₹6,00,000
Invest in ITI Pharma and Healthcare Fund
Start SIP from ₹500/month on these platforms
More Sectoral Funds
About Sectoral Funds
Sectoral mutual funds are a category defined by SEBI (Securities and Exchange Board of India) under their mutual fund categorization framework. These funds invest primarily in equities that match the sectoral profile, with specific allocation mandates that fund managers must follow. The category determines the fund's risk-return characteristics and its suitability for different investor profiles.
When evaluating a Sectoral fund like ITI Pharma and Healthcare Fund, key metrics to consider include: 3-year and 5-year CAGR (rolling returns are more reliable than point-to-point), expense ratio (Direct plans have lower costs), portfolio turnover, standard deviation (volatility measure), Sharpe ratio (risk-adjusted returns), and alpha generation over benchmark. A fund that consistently beats its benchmark index over multiple market cycles is a strong candidate.
For long-term wealth creation, Sectoral funds work best with a systematic investment plan (SIP) over 5+ years. SIP helps average out market volatility through rupee cost averaging. Lump sum investments are better timed during market corrections. Always ensure your mutual fund portfolio is diversified across 3-4 categories rather than concentrating in a single fund type. Consult a SEBI-registered investment advisor for personalized advice based on your financial goals and risk appetite.
Frequently Asked Questions
Is ITI Pharma and Healthcare Fund good for SIP?
ITI Pharma and Healthcare Fund is a Sectoral fund with moderate risk. For SIP investors, consistency of returns matters more than absolute returns. Check the fund's rolling returns and standard deviation before committing to a SIP. Sectoral funds are generally suitable for SIP with a minimum 5-year investment horizon for optimal results.
What is the risk level of this fund?
ITI Pharma and Healthcare Fund is categorized as moderate risk as per SEBI's riskometer methodology. This assessment considers market cap allocation, sector concentration, and historical portfolio volatility. This risk level indicates relatively stable returns with moderate portfolio fluctuation.
How to invest in this fund?
You can invest in ITI Pharma and Healthcare Fund (Direct-Growth plan) through platforms like Groww, Zerodha Coin, Kuvera, or directly from the AMC website. Minimum SIP amount starts at ₹500/month on most platforms. Complete KYC (PAN + Aadhaar verification) is mandatory before your first investment.
What are the tax implications?
For equity mutual funds in India: Short-term capital gains (units held less than 1 year) are taxed at 20%. Long-term capital gains (held more than 1 year) above ₹1.25 lakh in a financial year are taxed at 12.5%. ELSS funds have a mandatory 3-year lock-in period. Dividend income from mutual funds is added to your income and taxed at your applicable slab rate.